Becton Dickinson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Becton Dickinson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BDX

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. 

CEO
Thomas E. Polen
CEOThomas E. Polen
Employees
72,000
Employees72,000
Headquarters
Franklin Lakes, New Jersey
HeadquartersFranklin Lakes, New Jersey
Founded
1897
Founded1897
Employees
72,000
Employees72,000

BDX Key Statistics

Market cap
51.83B
Market cap51.83B
Price-Earnings ratio
57.24
Price-Earnings ratio57.24
Dividend yield
2.21%
Dividend yield2.21%
Average volume
1.67M
Average volume1.67M
High today
High today
Low today
Low today
Open price
$188.46
Open price$188.46
Volume
0.00
Volume0.00
52 Week high
$193.07
52 Week high$193.07
52 Week low
$129.03
52 Week low$129.03

Stock Snapshot

With a market cap of 51.83B, Becton Dickinson(BDX) trades at $190.21. The stock has a price-to-earnings ratio of 57.24 and currently yields dividends of 2.21%.

Becton Dickinson(BDX) stock opened on 2026-08-27 at $188.46. The price climbed to — and dipped to —.

Becton Dickinson(BDX) shares are trading with a volume of 0, against a daily average of 1.67M.

During the past year, Becton Dickinson(BDX) stock moved between $129.03 at its lowest and $193.07 at its peak.

During the past year, Becton Dickinson(BDX) stock moved between $129.03 at its lowest and $193.07 at its peak.

BDX News

TipRanks 2h
Becton Dickinson announces STANCE clinical trial enrollment milestone

Becton Dickinson (BDX) announced a milestone in its advanced tissue regeneration strategy and expansion efforts with the STANCE clinical trial evaluating GalaFL...

MarketWatch 6d
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch

...

Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
Simply Wall St 6d
Becton Dickinson Could Be Fully Valued On PREVENT Trial Enrollment Milestone

Becton Dickinson (BDX) has completed enrollment in its PREVENT clinical trial, a large randomized study testing Phasix Mesh for preventing incisional hernias in...

Becton Dickinson Could Be Fully Valued On PREVENT Trial Enrollment Milestone

Analyst ratings

50%

of 16 ratings
Buy
50%
Hold
50%
Sell
0%

People also own

Based on the portfolios of people who own BDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.